Newron Pharmaceuticals' H1 Net Loss Widens; Revenue Down

MT Newswires · 1d ago
01:09 AM EDT, 09/22/2026 (MT Newswires) -- Newron Pharmaceuticals (NWRN.SW) said Tuesday that its net loss for the first half widened, while revenue fell year over year. Net loss for the six months ended June 30 was 16.4 million euros, compared with a net loss of 73,000 euros a year ago. Loss per share moved to 0.798 euro from 0.004 euro. The pharmaceutical company's revenue was 3.2 million euros, compared with 11.9 million euros earlier.